drugset / Trial / NCT00581035
Study Evaluating the Safety and Ability to Produce Immune Response of Prevenar and Meningitec Given at the Same Time
RandomizedParallel-groupOpen-labelPrevention
Summary
The purpose of this study is to evaluate the safety and immunogenicity of concomitant Prevenar and Meningitec compared to Prevenar alone and Meningitec alone when used as part of the routine vaccination series in healthy infants
Timeline
- Start
- 2006-01
- Primary completion
- —
- Completion
- 2007-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Meningitec | Vaccine | — | — |
| Subject | Prevenar | Vaccine | — | — |
Indications
No indication recorded.